key: cord-1003326-exuo5cxh
authors: Bukhari, Syed Nasir Abbas; Ejaz, Hasan; Elsherif, Mervat A.; Janković, Nenad
title: Synthesis and Characterization of Dihydrouracil Analogs Utilizing Biginelli Hybrids
date: 2022-05-04
journal: Molecules
DOI: 10.3390/molecules27092939
sha: eaf28aa23dea796db8a7c1a63c8fccf9d50a8208
doc_id: 1003326
cord_uid: exuo5cxh

Dihydrouracil presents a crucial intermediate in the catabolism of uracil. The vital importance of uracil and its nucleoside, uridine, encourages scientists to synthesize novel dihydrouracils. In this paper, we present an innovative, fast, and effective method for the synthesis of dihydrouracils. Hence, under mild conditions, 3-chloroperbenzoic acid was used to cleave the carbon–sulfur bond of the Biginelli hybrids 5,6-dihydropyrimidin-4(3H)-ones. This approach led to thirteen novel dihydrouracils synthesized in moderate-to-high yields (32–99%).

Uracil is one of the nucleobases, and it can be found in RNA and as a significant constituent of the DNA of certain bacterial viruses [1] . The well-known intermediate scaffold dihydrouracil is a key precursor in the catabolism of uracil, a critical building block of life [2] . Several methods have been reported for the preparation of dihydrouracil [3] [4] [5] [6] [7] [8] [9] . However, most of these methods have certain drawbacks such as complicated multistep procedures [10, 11] , high energy consumption [12] , and air-sensitive organometallic compounds [4] . For instance, preparing a dihydrouracil scaffold is based on the hydrolytic removal of the SCH 3 or OCH 3 group from the dihydropyrimidinone core, which is carried out in strongly acidic and/or basic conditions and at high temperatures [4] . Methods for the synthesis of DHU scaffolds include quite difficult reaction conditions. For instance, formic acids and hydrochloric acid [6] were used under heating conditions to synthesize 6-aryl-dihydrouracils. Considering a literature review, the most successful method for synthesis of 6-aryl-DHU was published by Pair et al. [5] 6-Phenyl-5,6-dihydrouracil (37%) was synthesized by applying formic acid, MsOH, and heated to reflux for 24 h. Some representative uracil-based compounds are depicted in Figure 1 . N 1 -methylpseu douridine is the most important uracil analog and a natural archaeal tRNA component [13, 14] . Synthetic pyrimidine nucleoside is used for in vitro transcription and is also found in the SARS-CoV-2 mRNA vaccines tozinameran (Pfizer-BioNTech) and elasomeran (Moderna) [15] . Further, it is also used in vaccines against Zika [16] , HIV-1 [17] , and Ebola [18] . Dasabuvir, a potent non-nucleoside anti-HCV compound approved by the FDA in 2014, contains a uracil scaffold [19] . Furthermore, alkyl uracil derivatives show significant anti-HIV activity [20, 21] . By considering the literature, uracil-based biological active compounds, such as 5-iodouridine [22] , (S)-willardiine [23] , and zidovudine [24] , can also be found. Since 1957 to the present, the most helpful uracil molecule has been the well-known chemotherapeutic 5-fluorouracil [25] . Udayakumar et al. reported novel [24] , can also be found. Since 1957 to the present, the most helpful uracil molecule has been the well-known chemotherapeutic 5-fluorouracil [25] . Udayakumar et al. reported novel dihydrouracil derivatives with significant activities against A431 cancer cell lines [26] . Embrey et al. published a series of highly active DHU derivatives that contain naphthyridine scaffolds as HIV-1 integrase inhibitors at nanomolar levels [27] . The DHU analogues coupled with neomycin conjugates showed good activity against E. coli ATCC 25,922 and K12, even more potent compared to the control probe ciprofloxacin. In addition, few samples were more potent against Klebsiella pneumoniae than the control tetracycline [28] . Promising antimicrobial activity of selected N 3 -alkylated DHUs against S. aureus and C. albicans was described [29] . Considering the importance of DHU scaffolds [19] , there is a reasonable trend towards development of novel routes to synthesize uracil-based compounds. In this report, Biginelli's hybrids were chosen as starting materials for dihydrouracil (DHU) synthesis. Over the years, Biginelli chemistry has produced many valuable compounds that possess significant biological activities [30, 31] . Given these facts, as well as our continual interest in heterocyclic compounds [32] [33] [34] [35] and Biginelli chemistry [36] [37] [38] [39] [40] [41] , we decided to explore it to develop a novel and easier synthetic strategy for the synthesis of 6-aryl-dihydrouraciles (DHUs).

In this paper, a simple, fast, and efficient method for the synthesis of DHUs (2) from different 6-aryl-5,6-dihydropyrimidin-4(3H)-ones (1a-s) is presented (Scheme 1). The starting materials required for this methodology, 1a-s, were synthesized as a racemic mixture following published method [41] . Considering the importance of DHU scaffolds [19] , there is a reasonable trend towards development of novel routes to synthesize uracil-based compounds. In this report, Biginelli's hybrids were chosen as starting materials for dihydrouracil (DHU) synthesis. Over the years, Biginelli chemistry has produced many valuable compounds that possess significant biological activities [30, 31] . Given these facts, as well as our continual interest in heterocyclic compounds [32] [33] [34] [35] and Biginelli chemistry [36] [37] [38] [39] [40] [41] , we decided to explore it to develop a novel and easier synthetic strategy for the synthesis of 6-aryldihydrouraciles (DHUs).

In this paper, a simple, fast, and efficient method for the synthesis of DHUs (2) from different 6-aryl-5,6-dihydropyrimidin-4(3H)-ones (1a-s) is presented (Scheme 1). The starting materials required for this methodology, 1a-s, were synthesized as a racemic mixture following published method [41] .

Molecules 2022, 27, 2939 2 of 11 [24] , can also be found. Since 1957 to the present, the most helpful uracil molecule has been the well-known chemotherapeutic 5-fluorouracil [25] . Udayakumar et al. reported novel dihydrouracil derivatives with significant activities against A431 cancer cell lines [26] . Embrey et al. published a series of highly active DHU derivatives that contain naphthyridine scaffolds as HIV-1 integrase inhibitors at nanomolar levels [27] . The DHU analogues coupled with neomycin conjugates showed good activity against E. coli ATCC 25,922 and K12, even more potent compared to the control probe ciprofloxacin. In addition, few samples were more potent against Klebsiella pneumoniae than the control tetracycline [28] . Promising antimicrobial activity of selected N 3 -alkylated DHUs against S. aureus and C. albicans was described [29] . Considering the importance of DHU scaffolds [19] , there is a reasonable trend towards development of novel routes to synthesize uracil-based compounds. In this report, Biginelli's hybrids were chosen as starting materials for dihydrouracil (DHU) synthesis. Over the years, Biginelli chemistry has produced many valuable compounds that possess significant biological activities [30, 31] . Given these facts, as well as our continual interest in heterocyclic compounds [32] [33] [34] [35] and Biginelli chemistry [36] [37] [38] [39] [40] [41] , we decided to explore it to develop a novel and easier synthetic strategy for the synthesis of 6-aryl-dihydrouraciles (DHUs).

In this paper, a simple, fast, and efficient method for the synthesis of DHUs (2) from different 6-aryl-5,6-dihydropyrimidin-4(3H)-ones (1a-s) is presented (Scheme 1). The starting materials required for this methodology, 1a-s, were synthesized as a racemic mixture following published method [41] . The first goal of this project was to optimize the reaction conditions. Compound 1a was chosen as a model substrate for the study, and it was subjected to a variety of reagents, such as 6M HCl, sodium periodate, formic acid, and sodium hydroxide, in polar solvents (i.e., water, methanol, and THF) to synthesize 2a. Under these reagent and solvent conditions, compound 1a was decomposed into an unidentifiable mixture of products. However, the use of phosphotungstic acid in absolute ethanol gave DHU 2a in lower yield (30%) after 24 h. Subsequent attempts to synthesize 2a from 1a were realized by applying m-chloroperbenzoic acid (mCPBA) as the reagent in different solvents (Table 1) . The reaction was performed in six different solvents using an excess of mCPBA (2.2 eq.), and the desired product, 2a, was observed in five of those with DCM affording the maximum yield, 75% in 3 h (entry 5). To decipher the reasoning for the varying yields, we studied certain properties of these solvents such as the dielectric constants, polarity, and the index of the solvent dipolarity/polarizability. Water, DCM, THF, CHCl 3 , toluene, and dioxane have dielectric constants of 80, 9.1, 7.6, 4.8, 2.4, and 2.3, respectively [42, 43] . It has been shown that the higher polarity of a solvent affects the yield, but this effect is not alone; the hydrogen bond acceptor (HBA) ability of the solvent and the index of solvent dipolarity/polarizability π* can also influence the reaction. The HBA parameter describes the ability of the solvent to accept a proton in a solvent-to-solute hydrogen bond. Namely, THF, dioxane, and water have HBA numbers in the following order 0.52, 0.38, and 0.14, respectively (Table 2) [44, 45] . We suspect that the yield of 2a was negatively affected by the presence of the HBA properties of water, dioxane, or THF.= Toluene, DCM, and chloroform do not have HBA properties. Considering this, we proposed that the solvent molecule with HBA properties (i.e., dioxane, THF, and water) interacts with NH protons and, thus, make access of the reagent (mCPBA) to the reaction center (thioureide fragment; HN-(C-S-allyl)-N=) more difficult. This fact could be crucial for the such different (lower) yields achieved in a solvent with HBA (i.e., dioxane (32%), THF (29%), and water (-)) compared to the yield of 2a that was noted in solvents without HBA properties (i.e., toluene (51%), DCM (75%), and chloroform (40%)). In addition, the π* scale is an index that measures the ability of the solvent to stabilize a charge or a dipole by virtue of its dielectric effect. As can be seen from Table 2 , among non-HBA solvents (i.e., toluene, DCM, and CHCl 3 ), chloroform has the highest π* index (Table 2) . Reactions in chloroform and toluene gave 2a in similar yields (i.e., 40% and 51%, respectively). Both solvents do not have HBA properties (HBA = 0) and have a similar π* index (chloroform = 0.58 and toluene = 0.54; Table 2 ). The absence of HBA properties combined with a high π* index could be the reason for the highest yield for 2a achieved in a reaction carried out in DCM (HBA = 0 and π* index = 0.82) in comparison to toluene or chloroform. Table 2 . Solvent parameters (ε-dielectric constant; HBA-hydrogen bond acceptor number; π*-index of solvent dipolarity/polarizability) [45] . To investigate the scope of the reaction (Scheme 1), the same reaction conditions were applied (2 mmol of 1, 2.2 eq. of mCPBA and r.t., 3 h) to a series of 6-aryl-5,6dihydropyrimidin-4(3H)-ones (1b-s). In all these reactions, the targeted DHUs crashed out from the solution, which were isolated and characterized using NMR and IR spectroscopy after simple work up. In one case, a nearly quantitative yield was noted (2b, 99%). In general, the transformation afforded good-to-excellent yields of the product, except in the case of compound 1e with an o-chlorophenyl substitution (2e, 32%). A total of 19 DHUs were prepared among which 13 were prepared for the first time. The structures and isolated yields of these derivatives are presented in Figure 2 . To investigate the scope of the reaction (Scheme 1), the same reaction conditions were applied (2 mmol of 1, 2.2 eq. of mCPBA and r.t., 3h) to a series of 6-aryl-5,6-dihydropyrimidin-4(3H)-ones (1b-s). In all these reactions, the targeted DHUs crashed out from the solution, which were isolated and characterized using NMR and IR spectroscopy after simple work up. In one case, a nearly quantitative yield was noted (2b, 99%). In general, the transformation afforded good-to-excellent yields of the product, except in the case of compound 1e with an o-chlorophenyl substitution (2e, 32%). A total of 19 DHUs were prepared among which 13 were prepared for the first time. The structures and isolated yields of these derivatives are presented in Figure 2 . The applied reaction conditions showed good tolerance to the substituents on the aromatic ring. As a result, substrates with both an electron donating and an electron withdrawing group at the para position on the aromatic ring provided similar yields. For example, 4'-fluoro, -chloro, -nitro, and -benzyloxy gave the corresponding DHUs at 55, 87, 64 and 67%, respectively. Considering yield outcomes, the presence of alkoxy function The applied reaction conditions showed good tolerance to the substituents on the aromatic ring. As a result, substrates with both an electron donating and an electron withdrawing group at the para position on the aromatic ring provided similar yields. For example, 4'-fluoro, -chloro, -nitro, and -benzyloxy gave the corresponding DHUs at 55, 87, 64 and 67%, respectively. Considering yield outcomes, the presence of alkoxy function (methoxy(2j), ethoxy (2m), butoxy (2o), benzyloxy (2p), or 3'-methylbenzyloxy (2q)), even acetoxy group at para position (2s) also demonstrated good group tolerance. Interestingly, however, the aryl groups phenyl or antracen-10'-yl positioned at the C4 position, even though they possess similar electron-withdrawing behavior, realized different yields of DHU (75% of 2a and 99% of 2b) .

Going forward, we followed the reaction between 1a and mCPBA using 1 H NMR in CDCl 3 as a solvent (Figure 3 ). For this purpose, we prepared solutions of 1a (300 µL, 120 mM) and mCPBA (300 µL, 260 mM). Immediately after mixing, the first spectra were recorded. Six NMR spectra were then recorded every twelve hours. acetoxy group at para position (2s) also demonstrated good group tolerance. Interestingly, however, the aryl groups phenyl or antracen-10'-yl positioned at the C4 position, even though they possess similar electron-withdrawing behavior, realized different yields of DHU (75% of 2a and 99% of 2b) .

Going forward, we followed the reaction between 1a and mCPBA using 1 H NMR in CDCl3 as a solvent (Figure 3 ). For this purpose, we prepared solutions of 1a (300 μL, 120 mM) and mCPBA (300 μL, 260 mM). Immediately after mixing, the first spectra were recorded. Six NMR spectra were then recorded every twelve hours. As seen from stacked spectra in Figure 3 , the amide proton originating from 1a nearly disappeared. The intensity of the amide protons in the products increased (2a, green shapes; Figure 3) and was followed by a decrease in amide proton intensity from 1a (blue shape; Figure 3 ). Furthermore, mCPBA did not react with the double bond or even with the benzylic position. Double-bond protons showed the same multiplets in the range 5.1-5.4 ppm (=CH2) and 5.7-6.1 ppm (=CH) (Figure 3 ; orange shapes).

The NMR experiments provided us with valuable information: (a) the double bond did not react with peracid, even though mCPBA can easily transform the double bond into an epoxide ring; (b) benzylic protons originating from a dihydropyrimidine core is also sensitive to the presence of oxidants [39] , but the applied peracid had no significant effect on the chemical shifts of the benzylic protons, implying its stability under the applied conditions. Taking into account the data obtained from the NMR investigation, we proposed a plausible mechanism for the transformation (Figure 4 ). In the initial step, the sulfide group is oxidized into sulfoxide (II), which upon protonation forms intermediate III. Sulfoxide oxygen in intermediate III attacks C2, forming a C-O bond followed by cleavage of the C-S bond, and elimination of thiol can then give rise to the observed As seen from stacked spectra in Figure 3 , the amide proton originating from 1a nearly disappeared. The intensity of the amide protons in the products increased (2a, green shapes; Figure 3) and was followed by a decrease in amide proton intensity from 1a (blue shape; Figure 3 ). Furthermore, mCPBA did not react with the double bond or even with the benzylic position. Double-bond protons showed the same multiplets in the range 5.1-5.4 ppm (=CH 2 ) and 5.7-6.1 ppm (=CH) (Figure 3 ; orange shapes).

The NMR experiments provided us with valuable information: (a) the double bond did not react with peracid, even though mCPBA can easily transform the double bond into an epoxide ring; (b) benzylic protons originating from a dihydropyrimidine core is also sensitive to the presence of oxidants [39] , but the applied peracid had no significant effect on the chemical shifts of the benzylic protons, implying its stability under the applied conditions. Taking into account the data obtained from the NMR investigation, we proposed a plausible mechanism for the transformation (Figure 4 ). In the initial step, the sulfide group is oxidized into sulfoxide (II), which upon protonation forms intermediate III. Sulfoxide oxygen in intermediate III attacks C2, forming a C-O bond followed by cleavage of the C-S bond, and elimination of thiol can then give rise to the observed product 2a. A similar ring contraction in dihydropyrimidine compounds has already been suggested [46] .

In summary, an elegant approach to novel dihydrouracils has been developed. In most syntheses, moderate-to-high yields of target compounds were realized. The advantage of our method over existing ones is that we do not use metals, strong bases, or acids and work at room temperature. In addition, a simple work up process, good yields, and broad substrate scope could also be additional benefits of the presented method. After applying uracil's derivative (N 1 -methyl-pseudouridine) into COVID-19 vaccines, we firmly believe that uracil analogs have a bright future. Furthermore, the crucial importance of developing new approaches for the synthesis of dihydrouracil lies in the importance of these molecules, both in biological processes and in the development of new antiviral drugs.

Molecules 2022, 27, 2939 6 of 11 product 2a. A similar ring contraction in dihydropyrimidine compounds has already been suggested [46] . In summary, an elegant approach to novel dihydrouracils has been developed. In most syntheses, moderate-to-high yields of target compounds were realized. The advantage of our method over existing ones is that we do not use metals, strong bases, or acids and work at room temperature. In addition, a simple work up process, good yields, and broad substrate scope could also be additional benefits of the presented method. After applying uracil's derivative (N 1 -methyl-pseudouridine) into COVID-19 vaccines, we firmly believe that uracil analogs have a bright future. Furthermore, the crucial importance of developing new approaches for the synthesis of dihydrouracil lies in the importance of these molecules, both in biological processes and in the development of new antiviral drugs.

The melting points (mp) were determined on a Mel-Temp apparatus and were uncorrected. The IR spectra were recorded using a Perkin-Elmer Spectrum One FT-IR spectrometer on a KBr pellet. The NMR spectra of compounds 2a-s were performed in DMSO-d6 with TMS as the internal standard on a Varian Gemini 200 MHz NMR spectrometer ( 1 H at 200 and 13 C at 50 MHz). The abbreviations for the NMR signals that were used are s = singlet, d = doublet, t = triplet, m = multiplet, and br. s. = broad singlet. 1 H and 13 C spectra are given in the Supplementary Materials (Figures S1-S38 ). (2): in a 25 mL round-bottomed flask, appropriate dihydropyrimidine 1a-s (2 mmol) was dissolved in 5 mL of dichloromethane. Then, 2.2 eq of mCPBA was loaded at room temperature. The reactions were completed for 3 h. The precipitated product was filtered, washed with DCM, and dried in a vacuum. Dry powder was treated with saturated sodium bicarbonate solution, then filtrated, washed with water, and dried. 

The melting points (mp) were determined on a Mel-Temp apparatus and were uncorrected. The IR spectra were recorded using a Perkin-Elmer Spectrum One FT-IR spectrometer on a KBr pellet. The NMR spectra of compounds 2a-s were performed in DMSO-d 6 with TMS as the internal standard on a Varian Gemini 200 MHz NMR spectrometer ( 1 H at 200 and 13 C at 50 MHz). The abbreviations for the NMR signals that were used are s = singlet, d = doublet, t = triplet, m = multiplet, and br. s. = broad singlet. 1 H and 13 C spectra are given in the Supplementary Materials (Figures S1-S38) .

Synthesis of DHUs (2): in a 25 mL round-bottomed flask, appropriate dihydropyrimidine 1a-s (2 mmol) was dissolved in 5 mL of dichloromethane. Then, 2.2 eq of mCPBA was loaded at room temperature. The reactions were completed for 3 h. The precipitated product was filtered, washed with DCM, and dried in a vacuum. Dry powder was treated with saturated sodium bicarbonate solution, then filtrated, washed with water, and dried. Dihydro-6-(3'-(hexahydro-2",6"-dioxopyrimidin-4"-yl)phenyl)pyrimidine-2,4(1H,3H)-dione 2b: white powder; yield: 64%; Mp = 191 

'-Benzyloxyphenyl)-dihydropyrimidine-2,4(1H,3H)-dione 2h: white powder; yield: 67%

Mp = 209 • C; IR (KBr) ν 3432, 3209, 1737, 1696, 1514, and 1452 cm −1 ; 1 H NMR (200 MHz, DMSO-d 6 ) δ 10.16 (s, 1H, NH), 7.95 (s, 1H, NH), 7.46-7.22 (m, 7H, Ar)

Bromobenzyloxy)phenyl)-dihydropyrimidine-2,4(1H,3H)-dione 2i: white powder

Mp = 246 • C; IR (KBr) ν 3206, 3089, 1739, 1696, 1514, and 1456 cm −1 ; 1 H NMR

40 (d, J = 8.3 Hz, 2H, Ar), 7.25 (d, J = 8.6 Hz, 2H, Ar), 7.00 (d

Dihydro-6-(4'-methoxyphenyl)pyrimidine-2,4(1H,3H)-dione 2j: white powder

Mp = 220 • C; IR (KBr) ν 3256, 1731, 1692, and 1510, cm −1 ; 1 H NMR (200 MHz, DMSO-d 6 ) δ 10.14 (s, 1H, NH), 7.94 (s, 1H, NH), 7.24 (m, 2H, Ar)

4'-dimethoxyphenyl)-dihydropyrimidine-2,4(1H,3H)-dione 2k: white powder

93 (s, 1H, NH), 6.95-6.79 (m, 3H, Ar), 4.63-4.57 (m, 1H, CH), 3.74 (m, 6H, 2 × OCH 3 ), and 2.82-2.59 (m, 2H, CH 2 ) ppm; 13 C NMR (50 MHz, DMSOd 6 )

4',5'-trimethoxyphenyl)pyrimidine-2,4(1H,3H)-dione 2l: white powder; yield: 64%

Mp = 210 • C; IR (KBr) ν 3292, 3230, 1725, 1700, 1521, and 1462 cm −1 ; 1 H NMR

93 (s, 1H, NH), 6.66 (s, 2H, Ar), 4.64-4.58 (m, 1H, CH), 3.77 (s, 6H, 2 × OCH 3 ), 3.64 (s, 3H, OCH 3 ), and 2.82-2.61 (m, 2H, CH 2 ) ppm; 13 C NMR (50 MHz, DMSO-d 6 )

Ethoxy-3'-methoxyphenyl)-dihydropyrimidine-2,4(1H,3H)-dione 2m: white powder; yield: 68%

Mp = 221 • C; IR (KBr) ν 3233, 3078, 1699, 1523, 1478, and 1236 cm −1 ; 1 H NMR

59 (s, 1H, CH), 3.98 (q, J = 6.8 Hz, 2H, OCH 2 ), 3.75 (s, 3H, OCH 3 ), 2.82-2.59 (m, 2H, CH 2 ), and 1.31 (t, J = 6.9 Hz, 3H, CH 3 ) ppm; 13 C NMR (50 MHz, DMSO-d 6 )

Propoxy-3'-methoxyphenyl)-dihydropyrimidine-2,4(1H,3H)-dione 2n: yellow powder; yield: 63%

Mp = 205 • C; IR (KBr) ν 3220, 3095, 1717, 1685, and 1520 cm −1 ; 1 H NMR (200 MHz, DMSO-d 6 ) δ 10.15 (s, 1H, NH), 7.93 (s, 1H, NH), 6.92 (m, 2H, Ar), 6.79 (m, 1H, Ar)

Butoxy-3'-methoxyphenyl)-dihydropyrimidine-2,4(1H,3H)-dione 2o: white powder

Mp = 195 • C; IR (KBr) ν 3231, 3077, 1718, 1688, 1522, and 1476 cm −1 ; 1 H NMR

OCH 2 ), 3.75 (s, 3H, OCH 3 ), 2.82-2.58 (m, 2H

Benzyloxy-3'-methoxyphenyl)-dihydropyrimidine-2,4(1H,3H)-dione 2p: white powder

Ar), 6.82 (d, J = 9.6 Hz, 1H, Ar), 5.07 (s, 2H, OCH 2 ), 4.64-4.57 (m, 1H, CH), 3.77 (s, 3H, OCH 3 ), and 2.82-2.59 (m, 2H, CH 2 ) ppm; 13 C NMR (50 MHz, DMSO-d 6 )

-Methylbenzyloxy)-3'-methoxyphenyl)-dihydropyrimidine-2,4(1H,3H)-dione 2q: white powder; yield: 65%

02 (s, 2H, OCH 2 ), 4.60 (t, J = 5.5 Hz, 1H, CH), 3.77 (s, 3H, OCH 3 ), 2.82-2.59 (m, 2H, CH 2 ), and 2.31 (s, 3H, CH 3 ) ppm; 13 C NMR (50 MHz, DMSO-d 6 )

-Methylbenzyloxy)-3'-methoxyphenyl)-dihydropyrimidine-2,4(1H,3H)-dione 2r: white powder; yield

IR (KBr) ν 3395, 3201, 1729, 1695, and 1515 cm −1 ; 1 H NMR (200 MHz, DMSO-d 6 ) δ 10.15 (s, 1H, NH), 7.94 (s, 1H, NH), 7.31 (d, 2H, Ar), 7.18 (d, 2H, Ar)

Acetoxy-3'-methoxyphenyl)-dihydropyrimidine-2,4(1H,3H)-dione 2s: white powder; yield: 60%

Uracil in DNA-occurrence, consequences and repair

Relationships among plasma [2-13 C] uracil concentrations, breath 13 CO 2 expiration, and dihydropyrimidine dehydrogenase (DPD) activity in the liver in normal and DPD-deficient dogs

Chlorosulphonyl isocyanate addition to o-dialkylaminostyrenes: Preparation of 6-(Odialkylaminophenyl)-uracils

A new route to 5, 6-dihydropyrimidin-4 (3H)-ones

Modified multicomponent Biginelli-Atwal reaction towards a straightforward construction of 5,6-dihydropyrimidin-4-ones

Preparation of Beta-Amino Acids

Enzyme-catalyzed enantioselective hydrolysis of dihydrouracils as a route to enantiomerically pure β-Amino Acids

Dihydrouracil Compounds as Anti-Ictogenic or Anti-Epileptogenic Agents

DNA-protein cross-linking: Model systems for pyrimidinearomatic amino acid cross-linking

Solid-phase synthesis of 3-aminohydantoin, dihydrouracil, thiohydantoin and dihydrothiouracil derivatives

Synthesis of dihydrouracils spiro-fused to pyrrolidines: Druglike molecules based on the 2-arylethyl amine scaffold

A Synthesis of 5,6-Dihydrouracils in a Sealed-tube and Their Conformational Analysis

Identification of the enzyme responsible for N1-methylation of pseudouridine 54 in archaeal tRNAs

N1-methyl-pseudouridine in mRNA enhances translation through eIF2α-dependent and independent mechanisms by increasing ribosome density

The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines

Modified mRNA vaccines protect against Zika virus infection

Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses

Modified mRNA-based vaccines elicit robust immune responses and protect guinea pigs from Ebola virus disease

Chapter 8-Design and Development of HCV NS5B Polymerase Inhibitors

Unique chlorine effect in regioselective one-pot synthesis of 1-alkyl-/allyl-3-(o-chlorobenzyl) uracils: Anti-HIV activity of selected uracil derivatives

Synthesis and anti-HIV-1 and anti-HCMV activity of 1-substituted 3-(3,5-dimethylbenzyl) uracil derivatives

Synthesis and Antiviral Evaluation of Cis-Substituted Cyclohexenyl and Cyclohexanyl Nucleosides

Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptors

Structure-Based Design, Synthesis, and Biological Evaluation of Conformationally Restricted Novel 2-Alkylthio-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as Non-nucleoside Inhibitors of HIV-1 Reverse Transcriptase

Fluorinated pyrimidines, a new class of tumour-inhibitory compounds

A novel synthesis and preliminary in vitro cytotoxic evaluation of dihydropyrimidine-2,4(1H,3H)-dione derivatives

A series of 5-(5,6)-dihydrouracil substituted 8-hydroxy-[1,6] naphthyridine-7-carboxylic acid 4-fluorobenzylamide inhibitors of HIV-1 integrase and viral replication in cells

Multicomponent Domino Synthesis and Antibacterial Activity of Neomycin-Sugar Conjugates

Synthesis of Some New 3-Ethyl-6-phenylhexahydropyrimidine-2,4-dione Derivatives and Evaluation of Their In vitro Antimicrobial Activities

Current progress in asymmetric Biginelli reaction: An update

Recent Advances in Homogeneous and Heterogeneous Catalyst in Biginelli Reaction from 2015-19: A Concise Review

Molecular docking studies and biological evaluation of chalcone based pyrazolines as tyrosinase inhibitors and potential anticancer agents

Synthesis, molecular modeling, and biological evaluation of novel 1,3-diphenyl-2-propen-1-one based pyrazolines as anti-inflammatory agents

Synthesis, biological evaluation, docking study and ulcerogenicity profiling of some novel quinoline-2-carboxamides as dual COXs/LOX inhibitors endowed with anti-inflammatory activity

Synthesis and evaluation of chalcone analogues based pyrimidines as angiotensin converting enzyme inhibitors

Anticancer evaluation of the selected tetrahydropyrimidines: 3D-QSAR, cytotoxic activities, mechanism of action, DNA, and BSA interactions

Discovery of the Biginelli hybrids as novel caspase-9 activators in apoptotic machines: Lipophilicity, molecular docking study, influence on angiogenesis gene and miR-21 expression levels

Vanillic aldehydes for the one-pot synthesis of novel 2-oxo-1,2,3,4-tetrahydropyrimidines

Water ultrasound-assisted oxidation of 2-oxo-1,2,3,4-tetrahydropyrimidines and benzylic acid salts

On water synthesis of the novel 2-oxo-1,2,3,4-tetrahydropyrimidines

Water-Tuned Tautomer-Selective Tandem Synthesis of the 5,6-Dihydropyrimidin-4(3H)-ones, Driven under the Umbrella of Sustainable Chemistry

The acceptor number-A quantitative empirical parameter for the electrophilic properties of solvents

Pulse-Gradient Spin-Echo 1 H, 7 Li, and 19 F NMR Diffusion and Ionic Conductivity Measurements of 14 Organic Electrolytes Containing LiN(SO 2 CF 3 ) 2

The solvatochromic comparison method. I. The .beta.-scale of solvent hydrogen-bond acceptor (HBA) basicities

Linear solvation energy relationships. 23. A comprehensive collection of the solvatochromic parameters,. pi.*,. alpha., and. beta., and some methods for simplifying the generalized solvatochromic equation

Facile conversion of Biginelli 3, 4-dihydropyrimidin-2(1H)-thiones to 2-(2-hydroxy-2-arylvinyl) dihydropyrimidines via Eschenmoser coupling

The authors declare no conflict of interest.